Quick Takeaways
- Capitalink Ltd. filed SCHEDULE 13G for Clearmind Medicine Inc. Common Shares, no par value per share (CMND).
- Disclosed ownership: 10%.
- Date of event: 19 Nov 2025.
Capitalink Ltd. - 19 Nov 2025 SCHEDULE 13G Report for Clearmind Medicine Inc. Common Shares, no par value per share (CMND)
- Filing Manager
- Capitalink Ltd.
- Reporting Manager
- Capitalink Ltd.
- Symbol
- CMND
- Shares outstanding
- 33,106,016 shares
- Disclosed Ownership
- 3,307,291 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 01 Dec 2025, 16:15:11 UTC
- Date of event
- 19 Nov 2025
- Next filing
- 10 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Capitalink Ltd. disclosed 10% ownership in Clearmind Medicine Inc. Common Shares, no par value per share (CMND) on 19 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 01 Dec 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Capitalink Ltd. | 10% | 3,307,291 | 3,307,291 | 0 | /s/ Lavi Krasney | Chief Executive Officer |